Clinical analysis of 2019 coronavirus disease (COVID-19) on one case with living-related kidney transplantation/ 中华器官移植杂志

L. Xia, C. Ming, Z. Wen, L. Qiu, Shuyun Xu, Tao Chen, Q. Ning, Xiaoping Luo, Zhishui Chen, N. Gong
{"title":"Clinical analysis of 2019 coronavirus disease (COVID-19) on one case with living-related kidney transplantation/ 中华器官移植杂志","authors":"L. Xia, C. Ming, Z. Wen, L. Qiu, Shuyun Xu, Tao Chen, Q. Ning, Xiaoping Luo, Zhishui Chen, N. Gong","doi":"10.3760/CMA.J.CN421203-2020026-00049","DOIUrl":null,"url":null,"abstract":"Objective \nTo analyze the clinical characteristics of one living-related kidney transplant recipient infected with 2019 coronavirus disease (COVID-19) . \n \n \nMethod \nThe clinical diagnosis and treatment of one relative renal transplant recipient after the occurrence of COVID-19 were analyzed retrospectively, including the course of onset, clinical manifestations, blood routine test, renal function, lung CT scan, nucleic acid detection, outpatient and inpatient therapies and outcomes. \n \n \nResult \nThe case was diagnosed as COVID-19 (severe type) with influenza A virus infection. The clinical symptoms were gradually relieved and the lung lesions were absorbed through the treatment of reduce and stop taking immunosuppressant, antiviral therapy of abidol/oseltamivir, prevention of bacterial infection, hormone anti-inflammatory, oxygen inhalation, nutritional support and adequate rest. \n \n \nConclusion \nThis case present typical characteristics of COVID-19 in epidemiological investigation, clinical manifestation, examination, pulmonary imaging and etiology. After comprehensive treatment including reduce and stop immunosuppressive therapy, clinical cure was achieved. The long-term effect of COVID-19 on this immunosuppressive patient remains follow-up. \n \n \nKey words: \nCOVID-19; living-related kidney transplantation; recipient; immunosuppression; clinical characteristics","PeriodicalId":9885,"journal":{"name":"Chineae Journal of Organ Transplantation","volume":"56 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chineae Journal of Organ Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/CMA.J.CN421203-2020026-00049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Objective To analyze the clinical characteristics of one living-related kidney transplant recipient infected with 2019 coronavirus disease (COVID-19) . Method The clinical diagnosis and treatment of one relative renal transplant recipient after the occurrence of COVID-19 were analyzed retrospectively, including the course of onset, clinical manifestations, blood routine test, renal function, lung CT scan, nucleic acid detection, outpatient and inpatient therapies and outcomes. Result The case was diagnosed as COVID-19 (severe type) with influenza A virus infection. The clinical symptoms were gradually relieved and the lung lesions were absorbed through the treatment of reduce and stop taking immunosuppressant, antiviral therapy of abidol/oseltamivir, prevention of bacterial infection, hormone anti-inflammatory, oxygen inhalation, nutritional support and adequate rest. Conclusion This case present typical characteristics of COVID-19 in epidemiological investigation, clinical manifestation, examination, pulmonary imaging and etiology. After comprehensive treatment including reduce and stop immunosuppressive therapy, clinical cure was achieved. The long-term effect of COVID-19 on this immunosuppressive patient remains follow-up. Key words: COVID-19; living-related kidney transplantation; recipient; immunosuppression; clinical characteristics
2019冠状病毒病(COVID-19)活体肾移植1例临床分析
目的分析1例活体肾移植受者感染2019冠状病毒病(COVID-19)的临床特点。方法回顾性分析1例亲属肾移植受者发生COVID-19后的临床诊治情况,包括发病过程、临床表现、血常规、肾功能、肺部CT扫描、核酸检测、门诊和住院治疗及转归。结果该病例诊断为COVID-19(重症)合并甲型流感病毒感染。通过减少和停用免疫抑制剂、阿比妥/奥司他韦抗病毒治疗、预防细菌感染、激素抗炎、吸氧、营养支持、充分休息等治疗,临床症状逐渐缓解,肺部病变逐渐吸收。结论该病例在流行病学调查、临床表现、检查、肺部影像学及病因学等方面均具有典型的COVID-19特征。经减少、停止免疫抑制治疗等综合治疗,临床治愈。COVID-19对该免疫抑制患者的长期影响仍在随访中。关键词:COVID-19;活体肾移植;收件人;免疫抑制;临床特点
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信